Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
2
33%
Ph phase_2
1
17%
Ph not_applicable
2
33%
Ph phase_4
1
17%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(4)
Completed(2)

Detailed Status

Recruiting3
Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (33.3%)
Phase 21 (16.7%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

recruiting350%
not_yet_recruiting117%
completed233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DRUG
Total Trials
6